34,767 Shares in Globe Life Inc. $GL Acquired by Jupiter Topco LLC

Jupiter Topco LLC bought a new stake in Globe Life Inc. (NYSE:GL) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 34,767 shares of the company’s stock, valued at approximately $6,217,000.

Other large investors also recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC acquired a new position in shares of Globe Life during the 2nd quarter worth $28,000. Hilton Head Capital Partners LLC bought a new stake in Globe Life in the fourth quarter worth $30,000. MUFG Securities EMEA plc acquired a new position in Globe Life during the second quarter worth $31,000. Johnson Financial Group Inc. bought a new position in Globe Life during the second quarter valued at about $39,000. Finally, AdvisorNet Financial Inc lifted its position in shares of Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after buying an additional 92 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Insider Buying and Selling at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 25,650 shares of the firm’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the sale, the chief financial officer directly owned 50,568 shares in the company, valued at $9,030,433.44. This trade represents a 33.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the firm’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the sale, the chief executive officer owned 58,451 shares in the company, valued at $10,663,215.93. This represents a 46.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 151,908 shares of company stock valued at $27,239,981 in the last three months. 2.11% of the stock is owned by insiders.

Analysts Set New Price Targets

GL has been the topic of a number of analyst reports. Wells Fargo & Company increased their price objective on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. Keefe, Bruyette & Woods dropped their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research report on Friday, July 24th. Piper Sandler boosted their price objective on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Finally, Jefferies Financial Group upped their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Globe Life currently has an average rating of “Moderate Buy” and an average target price of $191.67.

Globe Life Price Performance

NYSE GL opened at $172.59 on Tuesday. The stock has a 50-day simple moving average of $178.78 and a 200 day simple moving average of $159.87. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55. The stock has a market capitalization of $13.26 billion, a PE ratio of 11.46 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $3.05 earnings per share. The business’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts anticipate that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life announced that its board has authorized a share repurchase program on Monday, August 10th that permits the company to buyback $2.50 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 17.7% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is 8.76%.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.